Prognostic Factors and the Impact of Various Management of Acute Myeloid Leukemia in Real Life Condition
The treatment of older patients with acute myeloid leukemia that is secondary to previous myelodysplastic syndrome, myeloproliferative neoplasm, or prior cytotoxic exposure remains unsatisfactory. We compared patients treated with intensive chemotherapy or azacitidine within two centres.
Acute Myeloid Leukemia
DRUG: intensive chemotherapy|DRUG: Azacitidine
Survival, Survival times, 2 years
The treatment of older patients with acute myeloid leukemia that is secondary to previous myelodysplastic syndrome, myeloproliferative neoplasm, or prior cytotoxic exposure remains unsatisfactory. We compared patients treated with intensive chemotherapy or azacitidine within two centres.